Ashland Global Holdings Inc ASH
We take great care to ensure that the data presented and summarized in this overview for ASHLAND GLOBAL HOLDINGS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ASH
View all-
Vanguard Group Inc Valley Forge, PA5.02MShares$430 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.47MShares$383 Million0.01% of portfolio
-
Eminence Capital, LP New York, NY3.15MShares$270 Million5.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.77MShares$237 Million0.07% of portfolio
-
Massachusetts Financial Services CO Boston, MA2.31MShares$198 Million0.07% of portfolio
-
Diamond Hill Capital Management Inc Columbus, OH1.93MShares$165 Million0.8% of portfolio
-
Clearbridge Investments, LLC New York, NY1.76MShares$150 Million0.14% of portfolio
-
Allspring Global Investments Holdings, LLC1.74MShares$149 Million0.24% of portfolio
-
State Street Corp Boston, MA1.65MShares$141 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY1.25MShares$107 Million0.02% of portfolio
Latest Institutional Activity in ASH
Top Purchases
Top Sells
About ASH
Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care & Household segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. Ashland Inc. was founded in 1924 and is based in Wilmington, Delaware.
Insider Transactions at ASH
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 04
2024
|
J Kevin Willis SVP and CFO |
SELL
Open market or private sale
|
Direct |
5,487
-24.34%
|
$477,369
$87.88 P/Share
|
Sep 03
2024
|
J Kevin Willis SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,487
+19.58%
|
$323,733
$59.95 P/Share
|
May 08
2024
|
James P. Minicucci SVP and GM, Personal Care |
SELL
Payment of exercise price or tax liability
|
Direct |
428
-31.38%
|
$41,516
$97.56 P/Share
|
May 08
2024
|
James P. Minicucci SVP and GM, Personal Care |
BUY
Exercise of conversion of derivative security
|
Direct |
1,364
+50.0%
|
$132,308
$97.56 P/Share
|
May 08
2024
|
Osama M Musa SVP and CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,123
-13.56%
|
$690,931
$97.56 P/Share
|
May 08
2024
|
Osama M Musa SVP and CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,698
+15.33%
|
$572,182
$59.68 P/Share
|
Feb 16
2024
|
Robin E. Lampkin SVP, Gen Counsel and Secrty. |
SELL
Open market or private sale
|
Direct |
844
-22.65%
|
$77,648
$92.54 P/Share
|
Jan 02
2024
|
Min Chong SVP, Gen. Mgr. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,853
-12.52%
|
$153,799
$83.7 P/Share
|
Jan 02
2024
|
Min Chong SVP, Gen. Mgr. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,900
+31.8%
|
$572,700
$83.7 P/Share
|
Dec 07
2023
|
Eric N Boni Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
843
-6.06%
|
$69,126
$82.38 P/Share
|
Dec 06
2023
|
Eric N Boni Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
843
+5.71%
|
$39,621
$47.63 P/Share
|
Nov 28
2023
|
Osama M Musa SVP and CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,092
-9.4%
|
$98,324
$47.63 P/Share
|
Nov 28
2023
|
Osama M Musa SVP and CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,825
+11.26%
|
$132,775
$47.36 P/Share
|
Nov 18
2023
|
Karl R. Bostaph SVP, OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
95
-1.72%
|
$7,410
$78.32 P/Share
|
Nov 18
2023
|
Karl R. Bostaph SVP, OPERATIONS |
BUY
Exercise of conversion of derivative security
|
Direct |
247
+4.29%
|
$19,266
$78.32 P/Share
|
Nov 18
2023
|
Osama M Musa SVP and CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
402
-2.03%
|
$31,356
$78.32 P/Share
|
Nov 18
2023
|
Osama M Musa SVP and CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,112
+5.31%
|
$86,736
$78.32 P/Share
|
Nov 18
2023
|
Guillermo Novo Chair of the Board and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,750
-2.49%
|
$214,500
$78.32 P/Share
|
Nov 18
2023
|
Guillermo Novo Chair of the Board and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,571
+5.61%
|
$512,538
$78.32 P/Share
|
Nov 18
2023
|
Swaminathan Ashok Kalyana |
SELL
Payment of exercise price or tax liability
|
Direct |
298
-8.15%
|
$23,244
$78.32 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 24.2K shares |
---|---|
Exercise of conversion of derivative security | 69.5K shares |
Payment of exercise price or tax liability | 36.2K shares |
---|---|
Open market or private sale | 7.17K shares |